General Discussions

 View Only

  • 1.  Input on Fee Schedule for Medtech/Innovation Projects

    Posted 09-29-2022 04:17
    Hi Everyone,

    Wondering if anyone other REB's are finding it difficult to determine what constitutes as For-Profit when charging fees to researchers. We are seeing a bunch of Medtech companies apply for REB approval now and we are looking to tighten up our language around the fees associated with the review for Industry Sponsored/For-Profit.

    Also, is your fee the same for Industry and For-Profit?


    Thanks,

    Krista

    ------------------------------
    Krista Rideout
    Ethics Director
    Memorial University of Newfoundland
    ------------------------------


  • 2.  RE: Input on Fee Schedule for Medtech/Innovation Projects

    TEAM CAYUSE
    Posted 10-06-2022 14:34

    Hi Krista,

    Let me tag a few other folks in Canada to see if they have any input! @Jim Rahaman, @Pamela Trenholm, @Christine Beswick, @Jennifer Couture.

    ​​​​

    ------------------------------
    Simon Helton
    He/him
    Community Manager
    Cayuse
    ------------------------------

    Original Message


  • 3.  RE: Input on Fee Schedule for Medtech/Innovation Projects

    Posted 10-07-2022 05:31
    Here is the link to our fee instructions for industry/sponsored projects:

    https://www.queensu.ca/vpr/ethics/hsreb/fees

    A one-time, non-refundable fee of $4,000 Canadian Dollars is required for all ethics reviews for industry funded and/or industry supported studies. The fee is also required for all in-kind support (e.g., drug, devices in kind), and external organizations seeking an independent REB review*.
    The REB review fee may be waived for: 

    1. Unfunded studies
    2. Internally funded studies (i.e. studies funded through internal awards/grants from Queen's University or affiliated hospitals Kingston Health Science Centre and Providence Care Centre) 
    3. Grant funded studies from a public, charitable or not‐for‐profit organization (e.g., Tri-agency, Canadian Cancer Society, Heart and Stoke Foundation)
    4. Studies initiated, authored and/or conducted by Queen's University affiliated researchers whereby the researcher owns all intellectual property and can alter the research without influence from the funder/not-for-profit organization 

    * A Board of Record agreement must be developed for all external REB reviews



    ------------------------------
    Jennifer Couture
    Manager, Research Ethics Compliance
    Queen's University
    ------------------------------

    Original Message


Related Content